ArticleOncotarget2018

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians.

Katharina C Kähler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.